Literature DB >> 10746234

Production and characterization of monoclonal antibodies reactive with the mycelial and yeast phases of Penicillium marneffei.

S Trewatcharegon1, S C Chaiyaroj, P Chongtrakool, S Sirisinha.   

Abstract

A definitive tissue diagnosis of Penicillium marneffei is hampered by a microscopic similarity to the yeast form of Histoplasma capsulatum and Cryptococcus neoformans. In order to obtain a better discrimination for accurate diagnosis, monoclonal antibodies (MAbs) were produced from hybridomas raised from Balb/c mice immunized with mycelial culture filtrate. By indirect immunofluorescent or immunoblot analysis, one immunoglobulin (Ig) G1 (3C2) MAb and three IgM (8B11, 3B9 and 8C3) MAbs were found to react strongly with P. marneffei antigens. In the immunoblots, the MAbs 8B11 and 3B9 reacted most strongly with a high molecular weight component (> 200 kDa) produced during either the mycelial or yeast phase of fungal growth. The immunoreactive epitopes for these two IgM MAbs were most likely associated with carbohydrate moieties, judging from their susceptibility to periodate oxidation and concanavalin A binding. This is in contrast to the immunoreactive epitopes for the MAbs 8C3 and 3C2, which were resistant to destruction by periodate treatment and did not bind to the lectin. Judging from immunofluorescent intensity, the three IgM MAbs could react strongly with the yeast cells present in the tissue biopsies of patients with P. marneffei infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746234     DOI: 10.1080/mmy.38.1.91.96

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  6 in total

1.  Antigen detection assay for identification of Penicillium marneffei infection.

Authors:  Sansanee C Chaiyaroj; Runglawan Chawengkirttikul; Stitaya Sirisinha; Pramuan Watkins; Yuttana Srinoulprasert
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 2.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum.

Authors:  K Prakit; J D Nosanchuk; K Pruksaphon; N Vanittanakom; S Youngchim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-02       Impact factor: 3.267

4.  Identification of Penicillium marneffei in Paraffin-Embedded Tissue Using Nested PCR.

Authors:  Hanxiang Zeng; Xiqing Li; Xiejie Chen; Junmin Zhang; Jiufeng Sun; Zhi Xie; Liyan Xi
Journal:  Mycopathologia       Date:  2009-03-24       Impact factor: 2.574

5.  Characterization of a novel yeast phase-specific antigen expressed during in vitro thermal phase transition of Talaromyces marneffei.

Authors:  Kritsada Pruksaphon; Mc Millan Nicol Ching; Joshua D Nosanchuk; Anna Kaltsas; Kavi Ratanabanangkoon; Sittiruk Roytrakul; Luis R Martinez; Sirida Youngchim
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

6.  Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei.

Authors:  Kritsada Pruksaphon; Akarin Intaramat; Kavi Ratanabanangkoon; Joshua D Nosanchuk; Nongnuch Vanittanakom; Sirida Youngchim
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.